Intestinibacter

—-

title: Intestinibacter type: entity subtype: microbe created: 2026-04-10 updated: 2026-04-16 last_substantive_update: 2026-04-16 sources: [dai-2024-gut-microbiota-cvd-bidirectional-mr, xiang-2023-host-gene-microbiome-crc-mr, wu-2017-metformin-gut-microbiome-t2d-nature-medicine, gutmann-2025-functional-microbiome-diet-ms, zheng-2025-gut-thyroid-axis-aitd-mendelian-randomization, bryrup-2019-metformin-gut-microbiota-healthy-young-men, dai-2024-bidirectional-mr-gut-microbiota-cvd] source_count: 7 metal_dependencies: [iron, cobalt] key_enzymes: [spore coat proteins, ferredoxin-dependent oxidoreductases, cobalt-dependent methionine synthase] tags: [pathobiont, spore-forming, context-dependent, CVD-protective, CRC-risk, Graves-disease-risk, metformin-sensitive, understudied] platform: wikibiome seo_target: "Intestinibacter bartlettii gut microbiome CVD colorectal cancer" wikipedia_differentiation: "Contradictory Mendelian randomization data showing CVD-protective but CRC-risk and Graves' disease-risk associations; iron and cobalt dependency; metformin-responsive; spore-forming persistence mechanism; represents the principle that gut bacteria can have tissue-specific opposite effects not captured by simple beneficial/harmful classification" conditions_enriched_in: [colorectal-cancer, graves-disease] conditions_depleted_in: [cardiovascular-disease] pathogenic_potential: commensal-turned-pathogen gram_stain: "positive" oxygen_requirement: "obligate anaerobe"—-

Intestinibacter bartlettii is a Gram-positive, obligate anaerobic, spore-forming bacterium within the Firmicutes phylum (Peptostreptococcaceae family). It is a relatively understudied gut commensal that has emerged in Mendelian randomization and metagenomic studies with contradictory associations across diseases — protective against cardiovascular disease but a causal risk factor for colorectal cancer and graves disease.

Taxonomy and Classification

• Type species of the genus Intestinibacter; reclassified from Clostridium bartlettii based on 16S rRNA phylogenetics.
• Family Peptostreptococcaceae, order Clostridiales, class Clostridia.
• The name Intestinibacter ("gut bacterium") reflects its primary ecological niche — it is a gut-adapted organism that only occasionally causes opportunistic infections.
• The genus was separated from Clostridium to accommodate its distinct phylogenetic position among the diverse Clostridiales lineages now known to be paraphyletic in the original taxonomy.

Spore-Forming Biology

A defining feature of I. bartlettii is its capacity to form endospores — heat-resistant, oxygen-tolerant, dehydration-tolerant dormant structures:

• Endospore formation enables survival during aerobic exposure, antibiotic treatment courses, starvation, and transit through the harsh upper GI environment.
• Once established in the colon, spore-formers are difficult to permanently eradicate because spores can persist through antibiotic courses and germinate when conditions improve.
• This persistence mechanism likely explains why Intestinibacter can be found in a wide range of disease states despite being a strict anaerobe — its spores may accumulate in dysbiotic environments where other obligate anaerobes are eliminated.
• Spore coat proteins require iron and cobalt cofactors during spore formation; metal availability during sporulation may influence spore dormancy characteristics.

Metal Dependencies

Iron:

• Ferredoxin-dependent oxidoreductases in the central anaerobic metabolism of Clostridiales require iron as an electron carrier. In I. bartlettii, these enzymes support fatty acid metabolism and energy generation from complex carbohydrates.
• Iron-dependent sporulation machinery: the sigma factor cascade controlling sporulation in Clostridium-related species involves iron-dependent regulatory proteins.

Cobalt:

• Cobalt-containing corrinoid (cobalamin/B12-like) enzymes participate in one-carbon metabolism and methionine biosynthesis via cobalt-dependent methionine synthase.
• Corrinoid-dependent metabolism is characteristic of many Clostridiales; it enables I. bartlettii to generate methyl donors for DNA methylation and SAM-dependent reactions, potentially influencing host epigenetic responses to microbial metabolites.

Cardiovascular Disease: Protective Role

Bidirectional Mendelian randomization provides causal evidence for a protective effect of Intestinibacter against multiple CVD outcomes ^[1]:

• Atrial fibrillation: Genetically predicted higher Intestinibacter abundance is protective (OR = 0.908, 95% CI calculated from GWAS summary statistics).
• Coronary artery disease: Protective effect independently supported (OR = 0.919).
• Intestinibacter is grouped with other butyrate-producing taxa (Coprococcus, Ruminiclostridium) as metal-sensitive protective organisms — taxa that are among those most vulnerable to depletion by heavy metal exposure.
• The proposed mechanism for CVD protection involves short-chain fatty acid (particularly butyrate) production, which reduces systemic inflammation and may directly protect vascular endothelium from oxidative damage.

These protective taxa being metal-sensitive means that metal-induced dysbiosis could selectively remove cardiovascular protection — a pattern consistent with the epidemiological association between heavy metal exposure and cardiovascular disease risk.

Colorectal Cancer: Causal Risk Factor

In contrast to its CVD-protective role, MR evidence identifies Intestinibacter as a causal risk factor for CRC with the strongest individual effect size among tested genera ^[2]:

• OR = 1.31 (P = 0.0038) — the largest causal risk effect identified in this genome-microbiome-CRC analysis.
• Replicated in an independent FinnGen validation cohort, supporting robustness beyond the discovery dataset.
• Meta-analysis combining Australian Gut Wide Association Study (AGWAS) and FinnGen results confirmed the causal association after multiple testing correction.

The paradox — protective in CVD but harmful in CRC — may reflect:

1. Tissue-specific metabolic effects: Butyrate is anti-inflammatory in the vascular endothelium but has complex dose-dependent effects on colonocyte proliferation — extremely high local butyrate production near the colonic epithelium could theoretically promote proliferation.
2. Spore-mediated immune modulation: Spore surface components may interact with colonic innate immune receptors differently from vegetative cell wall components, potentially suppressing anti-tumor surveillance.
3. Metabolic byproduct toxicity: Clostridiales-class fermentation can generate reactive metabolites (e.g., secondary bile acid deoxycholate precursors) that are directly genotoxic to colonocytes at high concentrations.

Graves' Disease: Risk Factor

A Mendelian randomization study of the gut-thyroid axis identified Intestinibacter as a causal risk factor for Graves' disease (OR = 1.777, P < 0.001 — the strongest individual risk effect in this study) ^[3]:

• The association is highly specific: Intestinibacter is a Graves' disease risk factor but the evidence for Hashimoto's thyroiditis uses different risk taxa (Intestinimonas, a related but distinct genus).
• Reverse MR showed no evidence of Graves' disease causally altering gut microbiota composition — directionality is microbiome → thyroid autoimmunity.
• The mechanism linking Intestinibacter to autoimmune thyroid disease may involve molecular mimicry (Clostridiales antigens cross-reacting with thyroid antigens), immune dysregulation via metabolite production, or spore-component stimulation of autoreactive T cell populations.

Metabolic and Dietary Associations

• Metformin sensitivity: Decreased by metformin treatment in type 2 diabetes patients ^[4], and in healthy young Danish men receiving metformin ^[5] — a finding that is reversible upon treatment cessation, confirming the metabolic rather than permanent nature of the effect.
• Dietary fiber metabolism: Linked to starch degradation pathways in the context of functional diet studies of multiple sclerosis, where I. bartlettii was associated with dietary fiber metabolism ^[6].
• The metformin sensitivity may explain part of the drug's reported cancer-preventive effect: reducing Intestinibacter as a CRC-risk taxon could be one mechanism among several.

The Context-Dependence Principle

The opposing CVD, CRC, and autoimmune thyroid associations of Intestinibacter exemplify a broader principle increasingly documented in microbiome research: single gut taxa can have tissue- and disease-specific effects that defy simple beneficial/harmful classification. Whether a taxon is "good" or "bad" depends on:

• Which disease endpoint is being assessed
• Local metabolite concentrations (butyrate is protective at physiological levels, potentially problematic at extremes)
• Systemic immune context (CVD involves low-grade systemic inflammation; CRC involves local immunosuppression; Graves' disease involves autoimmunity)
• The ecological community context in which Intestinibacter exists

This context-dependence is not a flaw in the data — it reflects the real biology of microbial community membership and the impossibility of characterizing any single taxon as universally beneficial or harmful.

Cross-References

• cardiovascular disease — MR-identified protective factor against atrial fibrillation and coronary artery disease
• colorectal cancer — MR-identified causal risk factor with the strongest effect size (OR=1.31)
• graves disease — MR-identified causal risk factor (OR=1.777); distinct from Hashimoto's thyroiditis risk taxa
• short chain fatty acids — Butyrate production is the proposed CVD-protective mechanism
• heavy metals — Classified among metal-sensitive butyrate producers vulnerable to dysbiosis-inducing metal exposure
• multiple sclerosis — Linked to starch degradation pathways in dietary MS studies
• iron — Required for ferredoxin-dependent oxidoreductases in central metabolism
• cobalt — Corrinoid enzyme cofactor in one-carbon metabolism
• dysbiosis — Metformin decreases Intestinibacter; dietary fiber modulates it
• nutritional immunity — Metal availability shapes expansion of this spore-forming taxon